MENU

DSGN Design Therapeutics Forecast, Technical & Fundamental Analysis

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations... Show more

DSGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
DSGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DSGN is expected to report earnings to rise 18.72% to -34 cents per share on November 11

Design Therapeutics DSGN Stock Earnings Reports
Q3'26
Est.
$-0.34
Q1'26
Beat
by $0.03
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.04
The last earnings report on April 28 showed earnings per share of -28 cents, beating the estimate of -31 cents. With 215.93K shares outstanding, the current market capitalization sits at 765.06M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
6005 Hidden Valley Road
Phone
+1 858 293-4900
Employees
54
Web
https://www.designtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSCWX23.45N/A
N/A
Nuveen Quant Small Cap Equity W
FBARX35.05N/A
N/A
Fidelity Advisor® Balanced C
GMXRX16.16N/A
N/A
Nationwide Mid Cap Market Idx R
MRFOX35.56N/A
N/A
Marshfield Concentrated Opportunity
CREHX10.40N/A
N/A
Columbia Real Estate Equity S

DSGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with RNA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-9.58%
RNA - DSGN
48%
Loosely correlated
-1.18%
FDMT - DSGN
40%
Loosely correlated
-0.94%
DYN - DSGN
38%
Loosely correlated
-3.35%
RCKT - DSGN
38%
Loosely correlated
-0.58%
SLDB - DSGN
37%
Loosely correlated
-4.23%
More
Design Therapeutics (DSGN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com